Sector Chart Lyell Immunopharma, Inc.

Equities

LYEL

US55083R1041

Market Closed - Nasdaq 21:00:00 17/05/2024 BST 5-day change 1st Jan Change
2.74 USD -1.44% Intraday chart for Lyell Immunopharma, Inc. +11.38% +41.24%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
709M -
114B
104B
22.41B -
22.28B -
19.07B